| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
2 companies
Roberts Eiry is a Director at FOLD with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $6.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sale+OE | 2,218 | $116.44 | $258,263.73 | -2.1% | +4.6% | +7.9% | |
| Feb 10, 2025 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sale+OE | 980 | $118.22 | $115,852.66 | -2.9% | +1.4% | +15.9% | |
| Jan 31, 2025 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sale+OE | 1,457 | $152.80 | $222,636.16 | -4.3% | -29.8% | -10.4% | |
| Feb 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sell | 1,114 | $132.96 | $148,121.78 | -4.5% | +1.7% | -12.4% | |
| Feb 8, 2024 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sell | 2,101 | $138.49 | $290,968.09 | -4.5% | +3.4% | -8.8% | |
| Jan 31, 2024 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sell | 1,457 | $140.79 | $205,131.90 | -6.5% | -1.6% | +9.7% | |
| Dec 22, 2023 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sell | 10,000 | $126.74 | $1,267,448.00 | -33.9% | +11.9% | +5.4% | |
| Dec 12, 2023 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sale+OE | 13,925 | $120.30 | $1,675,240.06 | -19.1% | +13.9% | +5.4% | |
| Dec 8, 2023 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sale+OE | 77,679 | $120.37 | $9,350,350.23 | -30.5% | +15.4% | +9.3% | |
| Dec 6, 2023 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sale+OE | 8,396 | $120.03 | $1,007,780.28 | -22.1% | +11.9% | +5.8% |